Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

NCT02181218 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, T-Cell, Cutaneous
Lymphoma, T-Cell, Peripheral
Hodgkin Disease
Lymphoma, Large B-Cell, Diffuse

Interventions

DRUG: Romidepsin
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Dexamethasone
DRUG: Pegfilgrastim

Sponsor

Washington University School of Medicine

Collaborators

[object Object]